Cyclerion Therapeutics (CYCN) Net Income towards Common Stockholders (QoQ) (2018 - 2025)
Cyclerion Therapeutics (CYCN) Net Income towards Common Stockholders (QoQ) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Cyclerion Therapeutics |
11.94 Mn |
8.70 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
39.83% |
| Jun 30, 2025 |
-14.76% |
| Sep 30, 2023 |
666.61% |
| Jun 30, 2023 |
36.87% |
| Mar 31, 2023 |
-30.21% |
| Dec 31, 2022 |
52.49% |
| Sep 30, 2022 |
54.67% |
| Jun 30, 2022 |
-3.46% |
| Mar 31, 2022 |
9.44% |
| Dec 31, 2021 |
-27.05% |
| Sep 30, 2021 |
30.24% |
| Jun 30, 2021 |
-20.76% |
| Mar 31, 2021 |
30.34% |
| Dec 31, 2020 |
11.34% |
| Sep 30, 2020 |
-11.02% |
| Jun 30, 2020 |
3.43% |
| Mar 31, 2020 |
22.36% |
| Dec 31, 2019 |
4.62% |
| Sep 30, 2019 |
15.31% |
| Jun 30, 2019 |
13.72% |
